Stool transplant with chemotherapy for advanced pancreatic cancer
Treatments studied
Part of Cancer, Digestive system clinical trials.
This study tests if giving patients a stool transplant (also called FMT) in capsules along with their first chemotherapy can help treat advanced pancreatic cancer that cannot be removed by surgery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older.
- You have been diagnosed with pancreatic cancer that cannot be removed by surgery or has spread to other parts of the body.
- You are starting your first chemotherapy for this cancer, with gemcitabine and nab-paclitaxel, and you've received at least one dose of each medicine.
- You have not had chemotherapy for pancreatic cancer before.
- You are not currently taking antibiotics and have not taken any in the last 7 days.
- You do not have severe food allergies (like to shellfish, nuts, or seafood), inflammatory bowel disease, or other serious health problems like uncontrolled heart disease or an active infection.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a fecal transplant (transferring healthy bacteria from a donor's stool into your gut) can help standard chemotherapy work better for triple negative breast cancer. It may also help your immune system fight the cancer.
This trial tests a new drug, pegcetacoplan, combined with a standard chemotherapy regimen called modified FOLFIRINOX, for people with pancreatic cancer that has spread to other parts of the body. The goal is to see if the combination helps control the cancer better than chemotherapy alone.
This trial tests whether a fecal transplant (a stool donation from a healthy person) can help patients with advanced stomach cancer respond better to treatment. If you qualify, you would receive the transplant through a colonoscopy, possibly along with other standard therapies.
This study tests whether transferring healthy bacteria from donor stool (FMT) into your gut can help control severe diarrhea after total pancreas removal. It may offer a new option when standard treatments haven't worked.
This trial tests whether combining fecal microbiota transplantation (FMT) with chemotherapy, radiotherapy, and immunotherapy before surgery can help shrink locally advanced rectal cancer that is MSS/pMMR. FMT involves transferring healthy donor stool to restore gut bacteria, which may boost treatment response.
This trial tests whether fecal transplants (putting healthy donor bacteria into your gut) can help with side effects like diarrhea, constipation, or nausea caused by cancer treatments. It is for people with advanced gastrointestinal cancer who are about to start their fourth round of chemo or targeted therapy.
Hear when a new Unresectable or Metastatic Advanced Pancreatic Ductal Adenocarcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.